Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is launching the new VisioNize® box 2,
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
Alembic Pharmaceutica
Since it’s an ingredient in so many foods, you h
Dear Readers,Welcome to the latest issue of Microb
During Friday trade the pharma stocks were the top gainer among the sectoral indices on NSE. The Nifty Pharma index was trading 3.02 per cent up at 8,502 around 12:25 pm. The pharma stocks were rallying amid a fresh fall in the Indian rupee against the US dollar.
The Sun Pharmaceuticals were the top gainer leading the pack (up 6.03 per cent), followed by Dr.Reddy’s Laboratories ( up 3.56 per cent) and Lupin ( up 3.38 per cent). Whereas Aurobindo Pharma (up 2.78 per cent), CadilaHealthcareNSE (up 2.64 per cent), Glenmark Pharmaceuticals (up 2.52 per cent), CiplaNSE (up 2.27 per cent) and Biocon (up 0.58 per cent) were also in the gainer’s list.
rnrn
As per the PTI reporter the Aurobindo Pharma said that they have received the final approval from the US health regulator to manufacture Omeprazole delayed-release tablets. These drugs are used for the treatment of frequent heartburn..
However, Divi’s laboratories and Piramal enterprises were the two stocks which were in the red.
As per the PTI reporter the Aurobindo Pharma said that they have received the final approval from the US health regulator to manufacture Omeprazole delayed-release tablets. These drugs are used for the treatment of frequent heartburn.
Among the 50 stocks in the nifty index, 16 were trading in the green where as 34 were in the red line.
